A perspective: role of targeted therapy in colon cancer

The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi

Volumn 61, Issue 3, 2013, Pages 128-135

  Chung, Hyun H ee ^a   Jang, Byung I k ^a  

^a Yeungnam University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; MATUZUMAB; MONOCLONAL ANTIBODY; PANITUMUMAB; VASCULOTROPIN A;

ANTAGONISTS AND INHIBITORS; COLONIC NEOPLASMS; HUMAN; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOLOGY;

ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS; BEVACIZUMAB; CETUXIMAB; COLONIC NEOPLASMS; HUMANS; MOLECULAR TARGETED THERAPY; RECEPTOR, EPIDERMAL GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84891392069     PISSN: 15989992     EISSN: None     Source Type: Journal    
DOI: 10.4166/kjg.2013.61.3.128     Document Type: Review

References (0)